You’ll Usually Only require One Injection While Your Symptoms Are At Their Worst.

Kissner joined Clearside in August 2014 as Senior Director, Development and has led Clearsides drug development programs for macular edema associated with non-infectious uveitis (currently in Phase 3) and wet age-related macular degeneration (AMD), which is currently in pre-clinical development with an Investigational New Drug (IND) submission to the U.S. and Drug Administration expected in the second half of 2016. Dr. Kissner has 14 years of clinical development experience for entities addressing sight-threatening diseases in positions at ophthalmology companies such as Alcon and Acucela. In Dr. Kissners new role, she will be responsible for leading the Companys clinical development strategy and team efforts by overseeing all aspects of the design, implementation, execution and management of clinical trial programs. Jennifer and Glenn represent a group of gifted researchers at Clearside who share a mission to treat patients suffering from sight-threatening diseases, said White. They have the level of experience and accomplishment that Clearside seeks to lead our scientific efforts to complete the development of valuable medicines like Zuprata using suprachoroidal drug delivery. About Clearside Biomedical, Inc. Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a publicly-traded, late-stage clinical biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye using Clearsides proprietary suprachoroidal space (SCS) microinjector to reach diseased tissue through the suprachoroidal space. Clearside holds intellectual property protecting the delivery of drugs of any type through the suprachoroidal space to reach the back of the eye. Clearside has a portfolio of clinical and pre-clinical programs using drug administration through the suprachoroidal space to provide a route of access to treat diseases of the back-of-the-eye like retinal vein occlusion (RVO), uveitis, wet AMD and diabetic macular edema (DME).

For the original version including any supplementary images or video, visit

ClasFification,.ymptoms, and Figns of uveitis. The urea is the middle layer of the eye which contains much of the eye’s blood vessels see diagram. Uveitis is a term used to describe a broad number of inflammatory diseases that produce swelling and redness within the eye, and ultimately destroys eye tissue. Also, uveitis may be caused by another disease or condition that, if left untreated, can lead to serious illness. Treatment can also lessen the risk of developing complications, such as glaucoma and cataracts . uveitis – Another form of uveitis, it affects the area just behind the biliary body pars plan and also the most forward edge of the retina.  If your uveitis was caused by another medical condition, you’ll need to make sure you’re getting the right treatment for it as well. Ono suede presenter Vesta afección si ha tenido LLuna infección generalizada sistémica o si padece una enfermedad autoinmunitaria. Na Cain bract Gastroenterol Hepatol. 2007;412:695-8. Carr Odin Ophthalmol. 2013;246:589-97. The iris regulates the amount of light that enters the eye, the biliary body produces aqueous humour and supports the lens, and the choroid provides oxygen and nourishment for the retina. She completed an internal medicine intern ship at St.

A body-wide infection is usually treated with antibiotics Treatment for intermediate uveitis includes steroid eye drops and steroids taken by mouth. This is referred to as a ‘hypopyon.’ fainter is a board-certified ophthalmologist. Short-term side effects of oral corticosteroids can include weight gain, increased appetite, mood changes such as feeling irritable or anxious, and insomnia. Antioxid redo Signal. 2001;36:1041-64. Depending on the type you have, your doctor may give you eye drops that have steroids to reduce the swelling, redness, and pain. You’ll usually only require one injection while your symptoms are at their worst. Medical Author: patrician S.

Leave a Reply

Your email address will not be published. Required fields are marked *